Antibodies, boosters, and optimizing SARS-CoV-2 vaccines for transplantation: A call for more research.

Ison, Michael G; Blumberg, Emily; Halasa, Natasha; Kaul, Dan; Theodoropoulos, Nicole M; Wolfe, Cameron R

Ison, Michael G; Blumberg, Emily; Halasa, Natasha; Kaul, Dan; Theodoropoulos, Nicole M; Wolfe, Cameron R.

Afiliação

Ison MG; Divisions of Infectious Diseases and Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Blumberg E; Division of Infectious Diseases, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Halasa N; Division of Pediatric Infectious Diseases, Vanderbilt University, Nashville, Tennessee, USA.
Kaul D; Division of Infectious Diseases, University of Michigan, Ann Arbor, Michigan, USA.
Theodoropoulos NM; Division of Infectious Diseases, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Wolfe CR; Division of Infectious Diseases, Duke University, Durham, North Carolina, USA.

Am J Transplant ; 22(1): 24-27, 2022 01.

Article em En | MEDLINE | ID: mdl-34241964

Assuntos

Vacinas contra COVID-19; COVID-19; Anticorpos Antivirais; Humanos; Estudos Prospectivos; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google